Nov
DEC
Jan
21
2014
2015
2016
1 captures
21 Dec 15 - 21 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Myocardial Infarction Clinical Trials
Primary PCI at Hospitals without On-Site Cardiac Surgery Increases Risk of Repeat Vascularization
Otamixaban May Reduce the Risk of Ischemic Events in Patients with NSTE-ACS
Genetic Variants Associated with Early Onset Myocardial Infarction also Associated with Need for Future Revascularization
Early Routine Eptifibatide Use is Not Superior to Delayed Provisional Use in NSTE ACS
Early Invasive Management Beneficial for High-Risk NSTEMI Patients
Positive Trends in FIRE Hint at Protection from Reperfusion Injury
Cardiac Arrhythmias and Risk Stratification after MI
Advantage of Prasugrel over Clopidogrel Holds across Range of Patient- and Procedure-Related Factors
Bavarian Reperfusion Alternatives Evaluation-3 Trial
Comparison of Prasugrel and Clopidogrel for Patients Undergoing PCI for ACS
Pages
Previous
Next
1
2
3
